BioMarin Pharmaceutical, Inc. (BMRN)
55.14
-0.94
(-1.68%)
USD |
NASDAQ |
Jan 15, 13:13
BioMarin Pharmaceutical SG&A Expense (TTM): 973.41M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amicus Therapeutics, Inc. | 353.07M |
| Gilead Sciences, Inc. | 5.886B |
| Merck & Co., Inc. | 10.70B |
| AbbVie, Inc. | 13.97B |
| Bristol Myers Squibb Co. | 7.222B |